Rick Moore is a Managing Partner at FCS and is based in the Philadelphia area. He is experienced in providing Commercial and Government Pricing compliance, Contracting, Gross to Net, Compliance and M&A support with a focus on Market Access and the management of associated operational, strategic, and financial risks for emerging, small, mid‐size, and top‐ten pharmaceutical and biotechnology manufacturers.
Prior to FCS Rick led the Pricing & Contracting Solutions (PaCS) Advisory practice at Deloitte where he oversaw and led a wide range of services around GP, FMV and BFSFs, State Price Transparency, Commercial Contract Strategy and Operations, and GTN.
He has led many high‐profile GP Assessments and restatements including litigation support for clients with alleged False Claims Act violations related to GP, assessments and restatements due to M&A, monitoring, and auditing from an OIG Settlement or other regulator requirement. Rick has a deep understanding of the dynamic healthcare ecosystem and has helped over 40 Pre‐Commercial or first US Commercial entrants stand up an infrastructure to comply and operate within the US Government and Commercial environment. Rick has worked with all types of life sciences organizations and products including brand, generics, and biosimilars, and has experience with the nuances of specialty, rare, and orphan biologics.